Results 31 to 40 of about 1,610,894 (277)

Tracking the tail

open access: yesJournal for ImmunoTherapy of Cancer, 2020
Immune-checkpoint inhibitors have deeply changed the therapeutic landscape of advanced non-small cell lung cancer without actionable genomic alterations. Immune-checkpoint inhibitors have become standard front-line therapy, especially among patients with
Alex Friedlaender   +2 more
doaj   +1 more source

PD-1 blockade enhances chemotherapy toxicity in oesophageal adenocarcinoma

open access: yesScientific Reports, 2022
Chemotherapy upregulates immune checkpoint (IC) expression on the surface of tumour cells and IC-intrinsic signalling confers a survival advantage against chemotherapy in several cancer-types including oesophageal adenocarcinoma (OAC).
Maria Davern   +10 more
doaj   +1 more source

Crossroad between the Heat Shock Protein and Inflammation Pathway in Acquiring Drug Resistance: A Possible Target for Future Cancer Therapeutics

open access: yesBiomedicines, 2023
The development of multidrug resistance (MDR) against chemotherapeutic agents has become a major impediment in cancer therapy. Understanding the underlying mechanism behind MDR can guide future treatment for cancer with better therapeutic outcomes ...
Prathap Somu   +7 more
doaj   +1 more source

Blocking CTLA-4 while priming with a whole cell vaccine reshapes the oligoclonal T cell infiltrate and eradicates tumors in an orthotopic glioma model

open access: yesOncoImmunology, 2018
Vaccine-mediated cancer treatment is unlikely to induce long-term survival unless suppressive mechanisms are overcome. Given the success of antibody-mediated immune checkpoint blockade in relieving regulation of endogenous anti-tumor T cell responses in ...
Cameron S. Field   +5 more
doaj   +1 more source

Supplementary Table from A Pan-Cancer Immunogenomic Atlas for Immune Checkpoint Blockade Immunotherapy

open access: yes, 2022
Supplementary Table from A Pan-Cancer Immunogenomic Atlas for Immune Checkpoint Blockade ...
Jing Wang (6206297)   +5 more
core   +1 more source

Broadening activity of checkpoint blockade agents by intratumoral nucleoside cleavage

open access: yesJCI Insight
We investigated whether destroying malignant cells and the associated tumor microenvironment (TME) by focal gene therapy would broaden immune checkpoint inhibitor (ICI) effectiveness. We show that ICI antitumor activity against syngeneic (murine) triple-negative breast cancer (TNBC) was augmented when a therapeutic transgene ...
Regina Rab   +11 more
openaire   +2 more sources

Neoadjuvant immune-checkpoint blockade in resectable colon cancer

open access: yes, 2020
Neoadjuvant checkpoint blockade achieves deep or complete pathologic responses in patients with mismatch-repair-deficient and mismatch-repair-proficient early colon ...
Coukos, G., George Coukos, Coukos G
core   +1 more source

Supplementary Data from A Pan-Cancer Immunogenomic Atlas for Immune Checkpoint Blockade Immunotherapy

open access: yes, 2022
Supplementary Data from A Pan-Cancer Immunogenomic Atlas for Immune Checkpoint Blockade ...
Jing Wang (6206297)   +5 more
core   +1 more source

Vγ9Vδ2 T Cells as Strategic Weapons to Improve the Potency of Immune Checkpoint Blockade and Immune Interventions in Human Myeloma

open access: yesFrontiers in Oncology, 2018
The advent of immune checkpoint (ICP) blockade has introduced an unprecedented paradigm shift in the treatment of cancer. Though very promising, there is still a substantial proportion of patients who do not respond or develop resistance to ICP blockade.
Barbara Castella   +6 more
doaj   +1 more source

Diagnosis and Management of Hepatitis in Patients on Checkpoint Blockade

open access: yes, 2018
Many human tumors are recognized by the adaptive immune system, but these spontaneous antitumor responses are typically inadequate to mediate regression.
Kerry Reynolds   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy